Clinical pharmacokinetics of the monoamine oxidase-A inhibitor moclobemide

Clinical Pharmacokinetics
M Mayersohn, T W Guentert

Abstract

There has been a resurgence of interest in the use of monoamine oxidase (MAO) enzyme inhibitors for the treatment of depression. Unlike the first-generation MAO inhibitors, the current drugs are readily reversible in their action, resulting in far less concern about interactions with certain foods and drugs which could lead to serious pressor effects. Furthermore, the current drugs are far more selective in their actions as a result of the ability to affect either the MAO-A or the MAO-B isoenzyme. Moclobemide is an example of a reversible MAO-A inhibitor which has been extensively studied and whose pharmacokinetic, clinical pharmacological and toxicological profiles have been thoroughly defined. Moclobemide has a short disposition half-life and intermediate values for systemic clearance and volume of distribution; half-life increases somewhat with dose. The drug is completely metabolised by the liver. Moclobemide is rapidly and completely absorbed following oral administration in a variety of dosages and forms. The drug has a high intrinsic (apparent oral) clearance which results in a substantial hepatic first-pass effect and, while there is marked interindividual variation, differences within an individual are small. A time- a...Continue Reading

Citations

Aug 1, 1996·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·S HärtterC Hiemke
Dec 31, 2003·Neurotoxicology·Mitsuhiko Yamada, Hajime Yasuhara
Apr 23, 2002·British Journal of Clinical Pharmacology·Joo-Youn ChoDong-Seok Yim
Oct 21, 2010·Breastfeeding Medicine : the Official Journal of the Academy of Breastfeeding Medicine·Riccardo DavanzoAlessandro Amaddeo
Jun 2, 2009·Clinical Neuropharmacology·Anatoly KreininVladimir Lerner
Sep 4, 2001·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·J HoskinsA Gross
Mar 15, 2005·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·D McKillopH C Swaisland
Apr 2, 2005·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·D McKillopM Hutchison
Sep 13, 2003·British Journal of Clinical Pharmacology·Geoffrey K IsbisterAnthony J Smith
Jul 31, 2007·British Journal of Clinical Pharmacology·Thomas M Polasek, John O Miners
May 25, 2010·Journal of Clinical Pharmacology·Anita Rakic IgnjatovicMilena Pokrajac
Nov 26, 2015·Archiv der Pharmazie·Vishnu N BadavathVenkatesan Jayaprakash
Feb 22, 2003·CNS Drug Reviews·Udo Bonnet
Jul 27, 1999·British Journal of Clinical Pharmacology·A D Van HaarstD G Musson
Jul 6, 2020·Naunyn-Schmiedeberg's Archives of Pharmacology·Adjia HamadjidaPhilippe Huot
Nov 4, 2004·British Journal of Clinical Pharmacology·Mireille V CantariniAndrew M Hughes
May 13, 1999·Cellular and Molecular Neurobiology·G B BakerS H Kennedy
May 13, 2021·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·C B EapC Hiemke

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.